Abstract
The incidence of regional lymph node (LN) involvement in patients with prostate cancer depends on several factors like the tumor size and the Gleason score (GS). The risk of LN involvement is <10% in low-risk disease. A number of models were developed in order to predict the risk of LN involvement which helps the physicians to decide whether to perform a staging lymphadenectomy or LN irradiation. In this chapter, we will review the current guidelines for the delineation of lymphatic target volumes in prostate cancer.
Cite
CITATION STYLE
Ozyigit, G., Yazici, G., Sari, S. Y., Gultekin, M., Hurmuz, P., & Akyol, F. (2017). Guidelines for the delineation of lymphatic target volumes in prostate cancer. In Principles and Practice of Urooncology: Radiotherapy, Surgery and Systemic Therapy (pp. 263–272). Springer International Publishing. https://doi.org/10.1007/978-3-319-56114-1_15
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
